Investors might want to bet on Lyra Therapeutics, Inc. (LYRA), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

On Tuesday, H.C. Wainwright analyst Matthew Caufield increased the price target on Lyra Therapeutics (NASDAQ: LYRA) shares to $16.00 from the previous $2.00 while maintaining a Neutral rating on ...

Following on from the futurist folk and pagan techno of 2020’s debut album Fountain, Berlin-based composer Lyra Pramuk has created Hymnal, a devotional symphony to the universe that moves from ...